Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells

Taken together, our results reveal that the preS-cSA/biotin-αCD205 vaccine induces effective immunological protection against HBV, and is a promising candidate for preventing HBV infections.